Informations sur le produit
- 3,5-Pyridinedicarboxylic acid
- 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-
- methyl 1-methylethyl ester (9CI)
- 3,5-Pyridinedicarboxylic acid
- 4-(4-benzofurazanyl)-2,6-dimethyl-
- methyl 1-methylethyl ester
- 2,1,3-Benzoxadiazole
- 3,5-pyridinedicarboxylic acid deriv.
- PN 203-831
- Methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl) -2,6-dimethylpyridine-3,5-dicarboxylate
- Voir d'autres synonymes
- Isopropyl methyl 4-(4-benzofurazanyl)-2,6-dimethyl-3,5-pyridinedicarboxylate
- Isradipine EP impurity D
- 4-(2,1,3-Benzoxadiazol-4-yl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester
- 4-(4-Benzofurazanyl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester
- Methyl Propan-2-Yl 4-(2,1,3-Benzoxadiazol-4-Yl)-2,6-Dimethylpyridine-3,5-Dicarboxylate
Applications The main metabolite of Isradipine.
References Tse, F., et al.: Eur. J. Clin. Pharmacol., 32, 361 (1987), Clifton, G., et al.: J. Clin. Pharmacol., 28, 36 (1988), Guengerich, F., et al.: J. Med. Chem., 34, 1838 (1991),